1,721,102 research outputs found
Perhexiline and hypertrophic cardiomyopathy: A new horizon for metabolic modulation
No full textJohn D. Horowitz and Yuliy Y. Chirko
Interplay between oxidative stress and inflammation in cardiometabolic syndrome
Full text linkEditorialAbstract not availableAaron L. Sverdlov, Gemma A. Figtree, John D. Horowitz and Doan T. M. Ng
Heart failure in older people: the epidemic we had to have
No full textJohn D Horowitz and Simon Stewar
Time to address the cardiac metabolic "triple whammy" - Ischemic heart failure in diabetic patients
No full textJohn D. Horowitz and Jennifer A. Kenned
Nitrate tolerance in arteries and platelets
No full textProf John D Horowitz$AUD 219,200.08NHMRC Project GrantsStandard Project Gran
Heart failure: a corin-deficient state?
No full textEditorial commentaryDoan T.M. Ngo, John D. Horowitz, Aaron L. Sverdlo
Optimization of efficacy of nitro-glycerine
No full textProf John D Horowitz$AUD 116,430.03NHMRC Project GrantsStandard Project Gran
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Homoarginine and 3-nitrotyrosine in patients with takotsubo cardiomyopathy
No full textArslan Arinc Kayacelebi, Thanh Ha Nguyen, Chris Neil, John D. Horowitz, Jens Jordan, Dimitrios Tsika
- …
